ArriVent BioPharma Inc
NASDAQ:AVBP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ArriVent BioPharma Inc
NASDAQ:AVBP
|
US |
|
Enstar Group Ltd
F:48R
|
BM |
|
A
|
Appro Photoelectron Inc
TPEX:6560
|
TW |
|
A
|
Arsy Buana Travelindo Tbk PT
IDX:HAJJ
|
ID |
|
Empress Royalty Corp
XTSX:EMPR
|
CA |
|
Ohki Healthcare Holdings Co Ltd
TSE:3417
|
JP |
|
G
|
Graincorp Ltd
XMUN:G3C
|
AU |
|
AppSwarm Corp
OTC:SWRM
|
US |
|
F
|
FedEx Corp
XHAM:FDX
|
US |
|
C
|
China Minsheng Banking Corp Ltd
XMUN:GHFH
|
CN |
|
Turaco Gold Ltd
ASX:TCG
|
AU |
|
F
|
Ferrari NV
F:2FE
|
IT |
|
H
|
Hartford Insurance Group Inc
F:HFF
|
US |
|
SPAR Group Ltd
OTC:SGPPF
|
ZA |
|
ANA Holdings Inc
OTC:ALNPF
|
JP |
|
Gail (India) Ltd
OTC:GAILF
|
IN |
Bankruptcy Probability
ArriVent BioPharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ArriVent BioPharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
A
|
ArriVent BioPharma Inc
NASDAQ:AVBP
|
807.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ArriVent BioPharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ArriVent BioPharma Inc has no debt.
You can find a full breakdown on its Balance Sheet.